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EFFECT OF CORTISOL LEVELS ON WORKING 
MEMORY PERFORMANCE IN ELDERLY 
SUBJECTS WITH ALZHEIMER’S DISEASE
Juliana Nery de Souza-Talarico1,2, Paulo Caramelli3, Ricardo Nitrini2, Eliane Corrêa Chaves1
Abstract – Background: Subjects with Alzheimer’s disease (AD) have elevated cortisol levels as a result of 
hypothalamic-pituitary-adrenal (HPA) axis dysfunction. Acute administration of hydrocortisone has been 
associated with working memory (WM) performance in young adults.  Objective: To investigate whether cortisol 
levels are associated with WM performance in subjects with AD.  Method: Eighty subjects were included, 
comprising 40 patients with mild AD and 40 healthy elderly controls. WM was assessed using the Digit Span       
Backward test (DSB). Saliva samples were collected to determine cortisol levels. Results: AD subjects had poorer 
performance on the DSB than controls (p=0.002) and also presented higher levels of cortisol than control 
group (p=0.04). No significant correlation was observed between the DSB and cortisol levels in both groups (r= 
–0.29).  Conclusion: In this study, elevated cortisol levels were not associated with poorer WM performance 
in patients with AD or in healthy elderly subjects.
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Efeito dos níveis de cortisol no desempenho da memória operacional de idosos com doença de Alzheimer
Resumo – Introdução: Idosos com doença de Alzheimer (DA) apresentam elevados níveis de cortisol como 
resultado de uma disfunção no eixo hipotálamo-pituitária-adrenal (HPA). A administração aguda de 
hidrocortisona tem sido associada ao desempenho da memória operacional (WM) em adultos jovens.  Objetivo: 
Investigar se os níveis de cortisol estão associados com o desempenho na WM em pacientes com DA.  Método: 
oitenta indivíduos foram incluídos, sendo 40 pacientes com DA leve e 40 idosos saudáveis controles. WM foi 
avaliada a partir do teste de Extensão de Dígitos na ordem direta (DSB). Amostras de saliva foram coletadas 
para determinar os níveis de cortisol.  Resultados: Indivíduos com DA apresentaram pior desempenho no 
DSB (p=0,002) e maiores níveis de cortisol (p=0,04) do que os controles. Não foi observada correlação 
significativa entre DSB e níveis de cortisol em nenhum dos grupos (r= –0,29).  Conclusão: Neste estudo, níveis 
de cortisol elevados não estão associados com pior desempenho da WM em pacientes com DA ou em idosos 
cognitivamente saudáveis.
PAlAvrAS-cHAvE: níveis de cortisol, memória operacional, doença de Alzheimer, idoso.
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Alzheimer’s disease (AD) is a chronic neurodegenera-
tive disorder which implies cognitive impairment including 
memory and executive dysfunction1. There is evidence that 
neuroendocrine dysfunctions may also be involved in the 
disease process, given that stress hormones affect neuro-
nal survival2. Moreover, elderly subjects prone to psycho-
logical distress are more likely to develop AD than non-
stressed individuals3. In the presence of stress stimuli, the 
hypothalamic-pituitary-adrenal (HPA) axis is stimulated 
and glucocorticoids (cortisol in primates, corticosterone 
in mice and rats) are released. Some studies have demon-
strated elevated cortisol levels in AD subjects resulting 
from HPA axis dysfunction, particularly in the earlier stag-
es of the disease4,5. Further, cortisol levels have been asso-
ciated with more rapid disease progression6 and increased 
b-amyloid and tau pathology in a mouse model of AD7.
considering the glucocorticoid receptors in the hip-
pocampus and prefrontal cortex8, cortisol levels can af-
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fect both declarative memory performance9, dependent 
on hippocampal activity, and working memory (WM)10, de-
pendent on frontal lobe functions. 
WM is the cognitive mechanism that allows the human 
brain to keep a limited amount of information active for a 
certain period11. Studies in nonhuman primates have dem-
onstrated that mild stress exposure impairs WM perfor-
mance12. In young adults, WM is more sensitive than de-
clarative memory to the acute administration of hydro-
cortisone8,13. However, the effect of endogenous cortisol 
levels on both healthy elderly subjects and individuals 
with AD remains unclear.
Given the presence of glucocorticoid receptors in the 
prefrontal cortex of humans and its relationship to WM, 
this study aimed to investigate whether endogenous cor-
tisol levels are associated with WM performance in pa-
tients with AD and in healthy elderly subjects.
METHOD
Participants 
Eighty subjects were included in the study, subdivided into 
two groups: the control Group, composed of 40 fully indepen-
dent elderly subjects with normal cognitive function, random-
ly chosen from a group of subjects participating in cultural ac-
tivities at the university campus (mean age±SD: 72.2±6.3 years; 
mean educational level±SD: 6.0±4.2 years), and the AD Group, 
composed of 40 elderly patients with mild AD (mean age±SD: 
80.1±6.0 years; mean educational level±SD: 4.7±2.6 years), who 
fulfilled NINcDS-ADrDA criteria14 for probable AD, having mild 
dementia according to the DSM-III-r criteria15, randomly chosen 
from the group of outpatients followed at the Behavioral and 
cognitive Neurology Unit (BcNU) of the Hospital das clínicas 
of the University of São Paulo School of Medicine (Hc-FMUSP). 
All data were collected after approval of the study by the Ethics 
and research committee of the Hc-FMUSP and School of Nurs-
ing of the University of São Paulo and written informed consent 
by all participants and their relatives.
For the control Group, exclusion criteria were elderly indi-
viduals diagnosed with any other neurological or psychiatric dis-
ease, with evidence of cognitive alterations incompatible with 
the norm for their age, having history of alcohol or drug abuse in 
the preceding year or for a previous prolonged period, individu-
als using psychoactive medication, as well as illiterate individu-
als. cognitive impairment was ruled out based on a combination 
of cognitive and functional evaluation instruments (Mini-Mental 
State Examination – MMSE16,17 and Informant Questionnaire on 
cognitive Decline – IQcoDE18,19). The MMSE16 was employed as 
a global measure of cognitive function and the following edu-
cation-adjusted cut-off scores were adopted for elderly individ-
uals without cognitive impairment: ≥28 for subjects with more 
than seven years of formal education, ≥24 for subjects with 4 
to 7 years and ≥23 for subjects with 1 to 3 years of schooling17. 
The IQcoDE was employed as a functional evaluation tool and 
a cut-off score ≤3.40 was adopted for individuals without cogni-
tive impairment19. The combination of these two screening tools 
can increase the diagnostic accuracy of dementia19. 
All individuals participating in the study were submitted to 
the study protocol evaluation, which included demographic data 
(gender, age and education level), working memory assessment 
(Digit Span test) and endogenous cortisol measurement.
Cognitive assessment
Working memory was evaluated using the Digit Span back-
ward (DSB) together with the difference between the Digit 
Span Forward (DSF) and backward scores (D DSF–DSB)20. The 
Digit Span test in the Wechsler batteries (the intelligence and 
memory scales) is the most commonly used measure of imme-
diate verbal recall. In these batteries it comprises two different 
tests, the DSF and DSB, each of which involves different men-
tal activities20. The DSF test is more closely related to atten-
tion efficiency, while the DSB test is related to working memo-
ry performance20. Both tests consist of six pairs of random digit 
sequences that the examiner reads aloud at the rate of one per 
second. In the DSF the subject has to repeat each sequence of 
digits exactly as is given, whereas in the DSB the subject has to 
repeat each sequence of digits in exact reverse order20. When 
a sequence is repeated correctly, the examiner reads the next 
longer digit sequence, continuing until the subject fails a pair of 
sequence or repeats the highest sequence correctly20. For each 
digit repeated correctly on either the DSF or DSB, the subject 
scores one point giving a maximum score of seven.
All evaluation instruments were administered by the same 
researcher (JNST) through individual interviews with the elder-
ly subjects. 
Cortisol measurement
Saliva samples were obtained from all subjects during the 
study to assay cortisol concentrations. This was done within two 
hours of waking in the next day after cognitive evaluation. Im-
mediately after sampling, saliva was placed on chipped ice and 
centrifuged within 2,200 rpm for 15min at 4ºc. Saliva was drawn 
off with pipette and transferred to a sterile tube and then dis-
tributed to samples of 0.5 ml that were stored at –20ºc un-
til assayed.
Saliva cortisol levels were determined with a radioimmuno-
assay kit (Amersham, Fleury S.A, São Paulo, Br) with [1,2,6,7-3H] 
cortisol as tracer (Kendall’s compound F), and cortisol F-79-I an-
tibody. The intra and inter assay coefficients of variation were 
6.8% and 3.9%, respectively.
Statistical analysis 
Initially, all variables were analyzed through descriptive sta-
tistics, with determination of means, standard deviations, and 
minimum/maximum values of the quantitative data (age, school-
ing, DSF and DSB scores). For the categorical variable gender, rel-
ative and absolute frequencies were calculated. Non-parametric 
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tests were used for those variables not presenting normal distri-
bution. The Mann-Whitney test was used to compare two inde-
pendent groups (AD and control), chi square to compare gender 
between control and AD groups, whereas Spearman’s correlation 
coefficient was used to study the correlation between DS test 
scores and cortisol levels, where the level of significance used 
for the test was 5% (p<0.05, 95% confidence interval).
RESULTS
In relation to demographic data, the two groups were 
similar in gender and educational level but showed a sig-
nificant difference regarding age. Demographic data are 
shown in Table.
Cognitive assessment
AD subjects presented a mean score of 6.1 (ranging 
from 4 to 7) on the DSF and a mean score of 3.2 (rang-
ing from 6 to 2) on the DSB. The maximum difference be-
tween DSF and DSB was 5 points in these subjects. The 
control Group presented better performance than AD 
subjects in all digit span tests, but a significant difference 
was obtain only on the DSB test. Therefore, AD subjects 
presented poorer working memory performance than 
control individuals. cognitive assessments are shown in 
Table. 
Cortisol measurement
AD subjects presented higher cortisol levels than con-
trol subjects (p=0.004). Although saliva samples were ob-
tained at slightly different times in AD subjects, with a 
mean of 1.46 hours from waking (ranging from 0.15 to 2.45 
hours) versus a mean of 1.51 hours (ranging from 0.30 to 
2.30 hours) in controls, no significant difference was ob-
served between the two groups (p=0.536; Mann-Whitney). 
Therefore, the different timings in saliva samples collec-
tion was not consider a confounder variable in the pres-
ent study, considering that both groups presented no dif-
ference in the interval between awaking time and saliva 
sample collections. Endogenous cortisol levels are shown 
in Figure 1.
Cortisol levels and working memory 
Those AD subjects who exhibited higher cortisol lev-
els presented worse DSB score, but this correlation did 
not attain statistical significance (p=0.062). No significant 
correlations were obtained between the DSF test and cor-
Table. Demographic characteristics and digit span scores in AD and control subjects.
variables AD (n=40)
N (%) or Mean (±SD)
control (n=40)
N (%) or Mean (±SD)
Statistical significance 
p (value)*
Sex (female) 27.0 (67.5) 35.0 (85.4) 0.31a
Age (years) 80.1±6.0 72.2±6.3 <0.01b
Education level (years) 4.7±2.6 6.0±4.2 0.34b
Ds forward 6.1±0.9 6.5±0.7 0.09b
Ds backward 3.2±0.9 3.8±1.2 0.02b
D forward and backward 2.9±1.2 2.6±1.1 0.32b
*value of less than 0.05 indicates significance; achi square test; bMann-Whitney test.
Fig 1. Distribution and means of cortisol levels in AD and control subjects. *The p value  of less than 0.05 indi-
cates significance, Mann-Whitney test. The error bars represent the standard error of the mean.
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tisol levels, or between the difference between the DSF 
and DSB tests and cortisol levels in both groups. lack of 
correlation is shown in Figure 2.
DISCUSSION
The results of this study revealed no significant ef-
fect of endogenous cortisol levels on WM performance 
in healthy elderly and AD subjects. Although AD subjects 
presented higher cortisol levels than controls, there was no 
significant association between elevated endogenous cor-
tisol levels and WM performance. Elevated cortisol levels 
in AD individuals were consistent with previous literature 
supporting the hypothesis that such elevation is a conse-
quence of neuronal injury in the hippocampus blocking 
inhibition of HPA axis activity and producing a repetitive 
cycle of increasing HPA dysfunction and ongoing hippo-
campal injury with consequent increase in cortisol levels21.
The fact that no significant correlation was observed 
between endogenous cortisol levels and the DSB in both 
groups is consistent with the possibility that WM is not 
sensitive to endogenous cortisol levels without an acute 
stressful situation. Several studies have demonstrated a 
significant correlation between administrations of hydro-
cortisone and memory performance, which are depen-
dent on frontal lobe functions in young subjects. In one 
such study, a significant impairment in the attention task 
after acute administration of 100 mg of hydrocortisone 
was reported22. Another study demonstrated WM deficits 
after 600 mg/kg/hr administration of hydrocortisone in 
young men, corresponding to an average dose of 42 mg 
for an individual weighing 70kg8, while visuo-spatial mem-
ory was impaired after chronic administration of 20 mg 
of hydrocortisone for 10 days. In all these studies mean 
cortisol levels after hydrocortisone administration were 
higher than 530 ng/dl.
Thus, one possible interpretation of our results is that 
endogenous cortisol levels were not sufficiently high to 
sensitize WM performance in our sample of AD subjects 
who presented a mean of 316 ng/dl of cortisol. This no-
tion is supported by a previous study which showed no 
association between WM impairment and a mean lower 
than 400 ng/dl of cortisol levels after acute administra-
tion of 30 mg of hydrocortisone23. It may be possible that 
the lack of association between endogenous cortisol lev-
els and WM is due to different sensitivities of this type of 
memory to cortisol rather than an absence of an effect of 
glucocorticoids on WM, whose interaction has also been 
demonstrated in previous studies24,25. Another point that 
has to be considered in the lack of correlation is related 
to small differences on WM scores and cortisol levels be-
tween control and AD group. correlations are more likely 
to be observed in small groups when there is a substantial 
variation in the range of the variables observed.
In addition, it should be raised that the cortisol levels 
obtained in the present study represents basal conditions. 
Maybe in an acute stressful situation which triggers the 
HPA axis resulting in relevant increases in cortisol levels 
would produces a different result. In previous literature, 
negative correlation was observed between cortisol levels 
induced by psychosocial stressor and WM performance26. 
Thus, on future studies should be interesting investigate 
the effect of cortisol levels on WM exposed to acute 
stressful situation.
There is evidence that mild stress exposure and in-
creases in corticosterone levels impair WM performance 
Fig 2. Lack of correlation between cortisol levels and digit span backward in AD and control subjects.
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mediated by high levels of dopamine in the prefrontal 
cortex27. Based on this interpretation, our results suggest 
that endogenous cortisol levels are not sufficient to sen-
sitize dopamine receptors, and consequently no effect 
on WM was produced. Additional studies examining glu-
cocorticoid and dopamine induced changes in prefrontal 
cortex using functional brain imaging are now necessary 
to support this hypothesis. 
Another interpretation for these results relates to 
age of the subjects. The effect of glucocorticoid on WM 
performance had been demonstrated in young individu-
als, while our study evaluated elderly subjects with and 
without cognitive impairment. Hence, it may be possible, 
considering the changes in dopamine activity which occur 
with aging, that glucocorticoids and dopamine receptor 
sensitivity differs between in young and elderly subjects28.
Despite the dissociation observed between endog-
enous cortisol levels and WM, it is important to consider 
that only a single cortisol measurement was obtained 
from subjects. Although no statistical difference was 
shown in the timing of saliva sample collection, the re-
liable standard for analyzing basal cortisol tends to in-
clude five measurements taken within 24 hours, preferably 
obtained from subjects at the same time during the day. 
This can avoid bias due to cortisol peaks in the morning 
compared with levels at other times of day. 
Furthermore, considering that changes in sleep pat-
terns are commonly observed in elderly subjects, this vari-
able may have played a role on our results. Sleep distur-
bances associated with poor cognitive performance and 
cortisol levels has been reported in elderly healthy con-
trols, being increased cortisol levels associated with poor 
sleep patterns and sleep-quality self-evaluation29. There-
fore, cortisol effects on cognitive performance covariate 
with sleep patterns could have revealed different results.
The fact that this study not replicated the associa-
tion between cortisol levels and WM reported in previous 
literature8,24,25 raised the question whether the cognitive 
performance observed in both AD and control groups tru-
ly represented presence or absence of dementia process. 
Although, we have carefully selected eligible control sub-
jects and AD based on diagnosis criteria widely described 
in the literature14,15, cases previously classified as “cogni-
tively normal” presenting neuropathological profile for 
AD or cerebrovascular disease (cvD) have been reported, 
being “cognitively normal” subjects proportionately more 
frequent in cvD (45%) than in AD (4%)30. In contrast, the 
same authors also reported subjects previously classified 
as “cognitively impaired” or “demented” with absence of 
neuropathological changes compatible with dementia 
process30. Therefore, the lack of association between cor-
tisol and WM observed in our study may be partially ex-
plained to the fact that control subjects and AD patients 
in early stages of disease could be mislead classified, since 
an infallible criteria remains under investigation.
In addition, the groups were different in relation to 
age and the sample generally small, and therefore, not so 
clinically meaningful. Future studies involving elderly in 
different age clusters and with a higher number of indi-
viduals are warranted, since these may show more con-
sistent results. 
In conclusion, despite the limitations of the present 
study, our findings confirm the occurrence of elevated 
cortisol levels in AD subjects together with the absence of 
WM sensitivity to this endogenous glucocorticoid. How-
ever, subjects with high levels of stress should undergo 
cortisol level assessment, given the negative effect that 
higher doses of this glucocorticoid may have on WM. 
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